GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Siegfried Holding AG (CHIX:SFZNz) » Definitions » 14-Day RSI

Siegfried Holding AG (CHIX:SFZNZ) 14-Day RSI : 35.27 (As of Dec. 15, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Siegfried Holding AG 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-12-15), Siegfried Holding AG's 14-Day RSI is 35.27.

The industry rank for Siegfried Holding AG's 14-Day RSI or its related term are showing as below:

CHIX:SFZNz's 14-Day RSI is ranked better than
88.58% of 1095 companies
in the Drug Manufacturers industry
Industry Median: 48.1 vs CHIX:SFZNz: 35.27

Competitive Comparison of Siegfried Holding AG's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siegfried Holding AG's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Siegfried Holding AG's 14-Day RSI falls into.



Siegfried Holding AG  (CHIX:SFZNz) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Siegfried Holding AG  (CHIX:SFZNz) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Siegfried Holding AG 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Siegfried Holding AG's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Siegfried Holding AG Business Description

Traded in Other Exchanges
Address
Untere Bruehlstrasse 4, Zofingen, CHE, CH-4800
Siegfried Holding is a global contract development and manufacturing organization, or CDMO. Siegfried derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. Siegfried provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 12 production sites on three continents.

Siegfried Holding AG Headlines

No Headlines